PMEF
Point72 Middle East FZE Portfolio holdings
AUM
$1.44B
1-Year Return
6.39%
This Quarter Return
+2.37%
1 Year Return
+6.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.77B
AUM Growth
+$467M
(+36%)
Cap. Flow
+$446M
Cap. Flow
% of AUM
25.26%
Top 10 Holdings %
Top 10 Hldgs %
19.38%
Holding
1,826
New
503
Increased
291
Reduced
226
Closed
774
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$121M |
| 2 |
NVIDIA
NVDA
|
+$31.8M |
| 3 |
Cigna
CI
|
+$25.8M |
| 4 |
Lowe's Companies
LOW
|
+$25M |
| 5 |
Visa
V
|
+$24.1M |
Top Sells
| 1 |
American International
AIG
|
+$15.4M |
| 2 |
Advanced Micro Devices
AMD
|
+$15.3M |
| 3 |
Booking.com
BKNG
|
+$14.2M |
| 4 |
Merck
MRK
|
+$13.4M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$12.6M |
Sector Composition
| 1 | Technology | 18.25% |
| 2 | Healthcare | 14% |
| 3 | Consumer Discretionary | 13.5% |
| 4 | Financials | 11.82% |
| 5 | Industrials | 10.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Primerica
PRI
$8.74B
| $252K | 0.01% |
+1,463
| New | +$252K |
|
427
Dynatrace
DT
$14.4B
| $251K | 0.01% |
+5,933
| New | +$251K |
|
428
Denali Therapeutics
DNLI
$2.14B
| $250K | 0.01% |
10,848
+7,255
| +202% | +$167K |
|
|
429
Regeneron Pharmaceuticals
REGN
$58.9B
| $247K | 0.01% |
301
-15,295
| -98% | -$12.6M |
|
430
Consolidated Edison
ED
$35B
| $247K | 0.01% |
+2,584
| New | +$247K |
|
431
Lincoln National
LNC
$7.88B
| $246K | 0.01% |
10,960
+6,478
| +145% | +$146K |
|
432
Dell
DELL
$84.2B
| $246K | 0.01% |
6,123
-11,890
| -66% | -$478K |
|
433
Madrigal Pharmaceuticals
MDGL
$9.59B
| $244K | 0.01% |
+1,009
| New | +$244K |
|
434
MGP Ingredients
MGPI
$588M
| $244K | 0.01% |
+2,518
| New | +$244K |
|
435
Expro
XPRO
$1.42B
| $242K | 0.01% |
+13,179
| New | +$242K |
|
436
Interactive Brokers
IBKR
$27.8B
| $241K | 0.01% |
+11,676
| New | +$241K |
|
437
Bumble
BMBL
$682M
| $240K | 0.01% |
12,277
+3,869
| +46% | +$75.6K |
|
438
M&T Bank
MTB
$31B
| $238K | 0.01% |
1,994
-4,738
| -70% | -$567K |
|
|
VERV
439
DELISTED
Verve Therapeutics
VERV
| $238K | 0.01% |
+16,498
| New | +$238K |
|
440
Hormel Foods
HRL
$13.7B
| $237K | 0.01% |
5,949
-32,320
| -84% | -$1.29M |
|
|
ESTE
441
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $237K | 0.01% |
18,199
-11,613
| -39% | -$151K |
|
442
Plexus
PLXS
$3.71B
| $236K | 0.01% |
2,418
+2,404
| +17,171% | +$235K |
|
443
Brady Corp
BRC
$3.69B
| $236K | 0.01% |
+4,386
| New | +$236K |
|
444
Intuit
INTU
$183B
| $232K | 0.01% |
520
-136
| -21% | -$60.6K |
|
445
Jamf
JAMF
$1.3B
| $230K | 0.01% |
11,859
+7,554
| +175% | +$147K |
|
446
DuPont de Nemours
DD
$31.9B
| $230K | 0.01% |
3,202
-24,617
| -88% | -$1.77M |
|
447
Factset
FDS
$13.7B
| $228K | 0.01% |
548
-7,639
| -93% | -$3.17M |
|
448
VanEck Junior Gold Miners ETF
GDXJ
$7.39B
| $227K | 0.01% |
+5,750
| New | +$227K |
|
449
RPC Inc
RES
$1.02B
| $226K | 0.01% |
29,358
+1,940
| +7% | +$14.9K |
|
450
TopBuild
BLD
$11.8B
| $225K | 0.01% |
+1,081
| New | +$225K |
|